Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Geron Corporation GERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.89
+248.5%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Geron Corporation (GERN), dont 35 achats et 9 ventes. Le total des achats d'initiés s'élève à $22.27M et le total des ventes d'initiés à $20.31M.

Les initiés notables ayant une activité récente comprennent Spiegel Robert J., Andrews Patricia S, Chinoporos Constantine. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — GERN

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-03-31 Spiegel Robert J. Director Attribution de RSU 5,243 $1.49 $7.81K 199,707
2026-03-25 Andrews Patricia S Officer Inconnu - - - -
2026-03-25 Andrews Patricia S Director Attribution de RSU 270,000 $1.57 $423.9K 270,000
2026-03-25 Chinoporos Constantine Officer Inconnu - - - -
2026-03-25 Chinoporos Constantine Director Attribution de RSU 270,000 $1.57 $423.9K 270,000
2026-02-18 Robertson Michelle EVP, Chief Financial Officer Vente Informative 9,855 $1.94 $19.12K 17,645
2026-02-17 Robertson Michelle EVP, Chief Financial Officer Attribution de RSU 1,660,000 $1.80 $2.99M 1,660,000
2026-02-17 Eid Joseph EVP, R&d; Chief Medical Office Attribution de RSU 2,220,000 $1.80 $4M 2,220,000
2025-12-31 Spiegel Robert J. Director Attribution de RSU 5,918 $1.32 $7.81K 194,464
2025-10-20 Elnawawi Ahmed EVP, Chief Commercial Officer Inconnu - - - 10,000
2025-10-20 Elnawawi Ahmed EVP, Chief Commercial Officer Attribution de RSU 3,000,000 $1.27 $3.81M 3,000,000
2025-09-30 Spiegel Robert J. Director Attribution de RSU 5,702 $1.37 $7.81K 188,546
2025-08-07 Semerjian Harout President and CEO Inconnu - - - -
2025-08-07 Semerjian Harout President and CEO Attribution de RSU 4,000,000 $1.30 $5.2M 4,000,000
2025-06-30 Spiegel Robert J. Director Attribution de RSU 5,540 $1.41 $7.81K 182,844
2025-05-21 Lawlis V Bryan Director Attribution de RSU 180,000 $1.34 $241.2K 180,000
2025-05-21 Spiegel Robert J. Director Attribution de RSU 180,000 $1.34 $241.2K 180,000
2025-05-21 Aggarwal Gaurav Director Attribution de RSU 180,000 $1.34 $241.2K 180,000
2025-05-21 Molineaux Susan Director Attribution de RSU 180,000 $1.34 $241.2K 180,000
2025-05-21 Bir Dawn Carter Interim President and CEO Attribution de RSU 180,000 $1.34 $241.2K 180,000
2025-05-21 O'farrell Elizabeth G. Director Attribution de RSU 180,000 $1.34 $241.2K 180,000
2025-05-21 Mcdonald John F Director Attribution de RSU 180,000 $1.34 $241.2K 180,000
2025-05-09 Lawlis V Bryan Director Achat Informatif 13,300 $1.18 $15.67K 13,300
2025-03-31 Spiegel Robert J. Director Attribution de RSU 4,913 $1.59 $7.81K 177,304
2025-02-27 Scarlett John A Chairman, President and CEO Achat Informatif 12,500 $1.77 $22.06K 12,500
2025-02-27 Samuels Scott Alan EVP, Chief Legal Officer Achat Informatif 15,000 $1.61 $24.15K 26,682
2025-02-27 Ziegler James EVP, Chief Commercial Officer Achat Informatif 100,000 $1.60 $160K 100,000
2025-02-18 Grethlein Andrew J EVP, Chief Operating Officer Attribution de RSU 140,000 - - 140,000
2025-02-18 Scarlett John A Chairman, President and CEO Attribution de RSU 410,000 - - 410,000
2025-02-18 Robertson Michelle EVP, Chief Financial Officer Attribution de RSU 110,000 - - 110,000
2025-02-18 Samuels Scott Alan EVP, Chief Legal Officer Attribution de RSU 104,000 - - 104,000
2025-02-18 Ziegler James EVP, Chief Commercial Officer Attribution de RSU 89,000 - - 89,000
2024-12-31 Spiegel Robert J. Director Retour de RSU 2,206 - - 172,391
2024-12-31 Spiegel Robert J. Director Attribution de RSU 2,206 $3.54 $7.81K 172,391
2024-11-11 Eid Joseph Officer Inconnu - - - -
2024-11-11 Eid Joseph EVP, Research and Development Retour de RSU 2,500,000 $4.12 $10.3M 2,500,000
2024-09-30 Spiegel Robert J. Director Retour de RSU 1,767 - - 170,185
2024-09-30 Spiegel Robert J. Director Attribution de RSU 1,767 $4.54 $8.02K 170,185
2024-09-09 Ziegler James Officer Inconnu - - - -
2024-09-09 Ziegler James EVP, Chief Commercial Officer Retour de RSU 1,600,000 $4.41 $7.06M 1,600,000
2024-07-08 Grethlein Andrew J EVP, Chief Operating Officer Exercice d'Options (Vente) 452,804 $1.72 $778.82K -
2024-06-28 Spiegel Robert J. Director Attribution de RSU 1,916 $4.24 $8.12K 168,418
2024-06-28 Spiegel Robert J. Director Retour de RSU 1,916 - - 168,418
2024-06-10 Kapur Anil EVP, Corp Strategy & Cco Vente Informative 421,875 $4.65 $1.96M -
2024-06-10 Feller Faye EVP, Chief Medical Officer Exercice d'Options (Vente) 155,400 $1.30 $201.24K -
2024-06-06 Grethlein Andrew J EVP, Chief Operating Officer Attribution de RSU 452,804 $1.72 $778.82K 452,804
2024-06-06 Scarlett John A Chairman, President and CEO Attribution de RSU 1,000,000 $1.72 $1.72M 1,000,000
2024-06-06 Kapur Anil EVP, Corp Strategy & Cco Attribution de RSU 250,000 $1.43 $357.5K 250,000
2024-06-06 Robertson Michelle EVP, Chief Financial Officer Attribution de RSU 250,000 $2.17 $542.5K 250,000
2024-06-06 Feller Faye EVP, Chief Medical Officer Attribution de RSU 50,000 $1.06 $53K 50,000
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message